Clinical Pharmacology: Advances and Applications

Dove Medical Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Pharmacology: Advances and Applications is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Dove Medical Press
ISSN
1179-1438
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,565 USD
Articles in DOAJ
269
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2010-12-21
Indexing
DOAJ
APC
3,565 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

269

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

310

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

41

i10-index

144

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2010-12-21
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
83%
ORCID iDs in current deposits
93%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Clinical pharmacology, advances and applications
Source type
journal
NLM unique ID (PubMed)
101564865
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
Show all subjects (50)
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cancer Treatment and Pharmacology
  • Pharmaceutical studies and practices
  • Metabolism, Diabetes, and Cancer
  • Cancer Treatment and Pharmacology
  • Anesthesia and Sedative Agents
  • Anesthesia and Sedative Agents
  • Metabolism, Diabetes, and Cancer
  • Pharmaceutical studies and practices
  • Cancer Immunotherapy and Biomarkers
  • Venous Thromboembolism Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Pharmacological Effects and Toxicity Studies
  • Drug-Induced Hepatotoxicity and Protection
  • Pharmacological Effects and Toxicity Studies
  • Lipoproteins and Cardiovascular Health
  • Venous Thromboembolism Diagnosis and Management
  • Cancer Immunotherapy and Biomarkers
  • Drug-Induced Hepatotoxicity and Protection
  • Colorectal Cancer Treatments and Studies
  • Intensive Care Unit Cognitive Disorders
  • Inflammatory mediators and NSAID effects
  • Multiple Myeloma Research and Treatments
  • HIV/AIDS drug development and treatment
  • Anesthesia and Pain Management
  • Epilepsy research and treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Intensive Care Unit Cognitive Disorders
  • Anesthesia and Pain Management
  • Epilepsy research and treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pharmacology and Obesity Treatment
  • Neuroscience and Neuropharmacology Research
  • Pharmacovigilance and Adverse Drug Reactions
  • Inflammatory mediators and NSAID effects
  • Neuroscience and Neuropharmacology Research
  • Pharmacovigilance and Adverse Drug Reactions
  • Colorectal Cancer Treatments and Studies
  • Multiple Myeloma Research and Treatments
  • HIV/AIDS drug development and treatment
  • Pharmacology and Obesity Treatment

Keywords (DOAJ)

  • pharmacology
  • drugs
  • clinical trials
  • drug safety

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: